• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sgo1是肝细胞癌的一个潜在治疗靶点。

Sgo1 is a potential therapeutic target for hepatocellular carcinoma.

作者信息

Wang Lyu-Han, Yen Chia-Jui, Li Tian-Neng, Elowe Sabine, Wang Wen-Ching, Wang Lily Hui-Ching

机构信息

Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan.

Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Oncotarget. 2015 Feb 10;6(4):2023-33. doi: 10.18632/oncotarget.2764.

DOI:10.18632/oncotarget.2764
PMID:25638162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4385833/
Abstract

Shugoshin-like protein 1 (Sgo1) is an essential protein in mitosis; it protects sister chromatid cohesion and thereby ensures the fidelity of chromosome separation. We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC. The depletion of Sgo1 reduced cell viability of hepatoma cell lines including HuH7, HepG2, Hep3B, and HepaRG. Using time-lapse microscopy, we showed that hepatoma cells were delayed and ultimately die in mitosis in the absence of Sgo1. In contrast, cell viability and mitotic progression of immortalized cells were not significantly affected. Notably, mitotic cell death induced upon Sgo1 depletion was suppressed upon inhibitions of cyclin-dependent kinase-1 and Aurora kinase-B, or the depletion of mitotic arrest deficient-2. Thus, mitotic cell death induced upon Sgo1 depletion in hepatoma cells is mediated by persistent activation of the spindle assembly checkpoint. Together, these results highlight the essential role of Sgo1 in the maintenance of a proper mitotic progression in hepatoma cells and suggest that Sgo1 is a promising oncotarget for HCC.

摘要

类守护蛋白1(Sgo1)是有丝分裂中的一种必需蛋白;它保护姐妹染色单体黏连,从而确保染色体分离的准确性。我们发现,Sgo1 mRNA在正常组织中的表达相对较低,但在82%的肝细胞癌(HCC)中上调,且与甲胎蛋白升高及HCC的疾病早期发作相关。Sgo1的缺失降低了包括HuH7、HepG2、Hep3B和HepaRG在内的肝癌细胞系的细胞活力。使用延时显微镜,我们发现肝癌细胞在没有Sgo1的情况下有丝分裂延迟并最终死亡。相比之下,永生化细胞的细胞活力和有丝分裂进程未受到显著影响。值得注意的是,当细胞周期蛋白依赖性激酶-1和极光激酶-B受到抑制,或有丝分裂阻滞缺陷蛋白-2缺失时,Sgo1缺失诱导的有丝分裂细胞死亡受到抑制。因此,肝癌细胞中Sgo1缺失诱导的有丝分裂细胞死亡是由纺锤体组装检验点的持续激活介导的。总之,这些结果突出了Sgo1在维持肝癌细胞正常有丝分裂进程中的重要作用,并表明Sgo1是一个有前景的HCC肿瘤靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/90baf61cb2ba/oncotarget-06-2023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/ce9e1582861a/oncotarget-06-2023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/6e6cc44a16fe/oncotarget-06-2023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/137f9c8417da/oncotarget-06-2023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/adab54f631b8/oncotarget-06-2023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/90baf61cb2ba/oncotarget-06-2023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/ce9e1582861a/oncotarget-06-2023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/6e6cc44a16fe/oncotarget-06-2023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/137f9c8417da/oncotarget-06-2023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/adab54f631b8/oncotarget-06-2023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2742/4385833/90baf61cb2ba/oncotarget-06-2023-g005.jpg

相似文献

1
Sgo1 is a potential therapeutic target for hepatocellular carcinoma.Sgo1是肝细胞癌的一个潜在治疗靶点。
Oncotarget. 2015 Feb 10;6(4):2023-33. doi: 10.18632/oncotarget.2764.
2
Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.Sgo1(守护蛋白1)单倍体不足小鼠肝脏致癌过程中额外染色体不稳定性的促癌/致癌作用
Carcinogenesis. 2015 Apr;36(4):429-40. doi: 10.1093/carcin/bgv011. Epub 2015 Mar 4.
3
Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.Cdc5L作为一种新型细胞周期蛋白在肝细胞癌中的表达及临床作用
Dig Dis Sci. 2016 Mar;61(3):795-805. doi: 10.1007/s10620-015-3937-9. Epub 2015 Nov 9.
4
Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.三种联合的THOC5 mRNA输出蛋白靶基因的缺失协同诱导人肝癌细胞死亡。
Oncogene. 2016 Jul 21;35(29):3872-9. doi: 10.1038/onc.2015.433. Epub 2015 Nov 9.
5
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.一种在肝细胞癌中上调的新型预后生物标志物SPC24。
Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.
6
Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.在肝癌细胞中抑制辅伴侣蛋白CDC37会抑制细胞周期进程和细胞生长。
Liver Int. 2015 Apr;35(4):1403-15. doi: 10.1111/liv.12651. Epub 2014 Aug 25.
7
[The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].[miR-130b在人肝细胞癌中的表达及临床病理意义]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Mar;32(3):387-92.
8
SGO1C is a non-functional isoform of Shugoshin and can disrupt sister chromatid cohesion by interacting with PP2A-B56.SGO1C是守护蛋白的一种无功能异构体,可通过与PP2A-B56相互作用破坏姐妹染色单体黏连。
Cell Cycle. 2015;14(24):3965-77. doi: 10.1080/15384101.2015.1104439.
9
Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.长链非编码RNA NEAT1通过调控miR-129-5p-VCP-IκB促进肝癌细胞增殖。
Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G150-G156. doi: 10.1152/ajpgi.00426.2016. Epub 2017 May 19.
10
Human Bub1 protects centromeric sister-chromatid cohesion through Shugoshin during mitosis.人类Bub1在有丝分裂过程中通过守护蛋白保护着丝粒姐妹染色单体黏连。
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18012-7. doi: 10.1073/pnas.0408600102. Epub 2004 Dec 16.

引用本文的文献

1
Taming Pancreatic Cancer: Kurz-Derived 4-Hydroxy-2-Methoxy-6-Tridecylphenyl Acetate as a Potent Tubulin Polymerization Inhibitor for Targeted Pancreatic Ductal Adenocarcinoma Therapy.驯服胰腺癌:库尔兹衍生的4-羟基-2-甲氧基-6-十三烷基苯基乙酸酯作为一种有效的微管蛋白聚合抑制剂用于靶向胰腺导管腺癌治疗。
Int J Med Sci. 2025 Jan 13;22(3):651-661. doi: 10.7150/ijms.104112. eCollection 2025.
2
Haploinsufficiency and Alzheimer's Disease: The Possible Pathogenic and Protective Genetic Factors.单倍体不足与阿尔茨海默病:可能的致病和保护遗传因素。
Int J Mol Sci. 2024 Nov 7;25(22):11959. doi: 10.3390/ijms252211959.
3
Shugoshin 1 expression in various cancers: a potential target for therapy.

本文引用的文献

1
SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers.SGOL1 变体 B 可诱导非小细胞肺癌中的异常有丝分裂和对紫杉烷类药物的耐药性。
Sci Rep. 2013 Oct 22;3:3012. doi: 10.1038/srep03012.
2
Antimitotic drugs in cancer chemotherapy: promises and pitfalls.抗癌化疗中的抗有丝分裂药物:前景与陷阱。
Biochem Pharmacol. 2013 Sep 15;86(6):703-10. doi: 10.1016/j.bcp.2013.07.010. Epub 2013 Jul 22.
3
The genomic and transcriptomic landscape of a HeLa cell line.一个 HeLa 细胞系的基因组和转录组景观。
多种癌症中守护蛋白1的表达:一种潜在的治疗靶点
Clin Transl Oncol. 2025 May;27(5):1953-1966. doi: 10.1007/s12094-024-03749-1. Epub 2024 Oct 30.
4
Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.SGOL1 在肾透明细胞癌中的预后和生物学功能:多组学分析。
BMC Med Genomics. 2024 Feb 21;17(1):60. doi: 10.1186/s12920-024-01825-7.
5
Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer.持续下调守护蛋白1可减少三阴性乳腺癌小鼠异种移植瘤模型中的肿瘤生长和转移。
Cell Div. 2023 Apr 30;18(1):6. doi: 10.1186/s13008-023-00088-5.
6
SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma.SGOL2是一种新型的预后标志物,通过MAD2介导的途径促进肝细胞癌的疾病进展。
Biomark Res. 2022 Nov 15;10(1):82. doi: 10.1186/s40364-022-00422-z.
7
A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma.一种用于预测肝细胞癌预后的与细胞周期相关的13-信使核糖核酸特征
Front Oncol. 2022 Mar 28;12:760190. doi: 10.3389/fonc.2022.760190. eCollection 2022.
8
High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma.高 SGO2 表达预示总生存期不良:肝细胞癌的潜在治疗靶点。
Genes (Basel). 2021 Jun 7;12(6):876. doi: 10.3390/genes12060876.
9
Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel.黏连蛋白-蛋白守护蛋白-1通过HCN4起搏器通道控制心脏自律性。
Nat Commun. 2021 May 5;12(1):2551. doi: 10.1038/s41467-021-22737-5.
10
Role of E2Fs and mitotic regulators controlled by E2Fs in the epithelial to mesenchymal transition.E2Fs 和受其调控的有丝分裂调节因子在上皮间质转化中的作用。
Exp Biol Med (Maywood). 2019 Nov;244(16):1419-1429. doi: 10.1177/1535370219881360. Epub 2019 Oct 1.
G3 (Bethesda). 2013 Aug 7;3(8):1213-24. doi: 10.1534/g3.113.005777.
4
Phosphorylation-enabled binding of SGO1-PP2A to cohesin protects sororin and centromeric cohesion during mitosis.磷酸化介导的 SGO1-PP2A 与黏连蛋白的结合在有丝分裂过程中保护着 Sororin 和着丝粒黏合。
Nat Cell Biol. 2013 Jan;15(1):40-9. doi: 10.1038/ncb2637. Epub 2012 Dec 16.
5
A novel treatment strategy targeting shugoshin 1 in hematological malignancies.靶向血液系统恶性肿瘤中的 shugoshin 1 的新型治疗策略。
Leuk Res. 2013 Jan;37(1):76-82. doi: 10.1016/j.leukres.2012.10.002. Epub 2012 Oct 24.
6
Mitosis-targeted anti-cancer therapies: where they stand.有丝分裂靶向抗癌疗法:现状如何。
Cell Death Dis. 2012 Oct 18;3(10):e411. doi: 10.1038/cddis.2012.148.
7
Shugoshins function as a guardian for chromosomal stability in nuclear division.纺锤体检查点蛋白作为染色体稳定的守护者在核分裂中发挥作用。
Cell Cycle. 2012 Jul 15;11(14):2631-42. doi: 10.4161/cc.20633.
8
Improved chemotherapy for hepatocellular carcinoma.改善肝细胞癌的化疗。
Anticancer Res. 2012 Apr;32(4):1379-86.
9
Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis.SGO1 杂合性缺失导致中心体动力学失调、染色体不稳定性增强和结肠肿瘤发生。
Cell Cycle. 2012 Feb 1;11(3):479-88. doi: 10.4161/cc.11.3.18994.
10
A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion.一种新型肿瘤源性 SGOL1 变异导致异常有丝分裂和不稳定的染色单体粘连。
Oncogene. 2011 Nov 3;30(44):4453-63. doi: 10.1038/onc.2011.152. Epub 2011 May 2.